CN104780906A - 注射器 - Google Patents
注射器 Download PDFInfo
- Publication number
- CN104780906A CN104780906A CN201380028946.2A CN201380028946A CN104780906A CN 104780906 A CN104780906 A CN 104780906A CN 201380028946 A CN201380028946 A CN 201380028946A CN 104780906 A CN104780906 A CN 104780906A
- Authority
- CN
- China
- Prior art keywords
- syringe
- plunger
- stopper
- bar
- main body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012530 fluid Substances 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims description 37
- 238000000034 method Methods 0.000 claims description 21
- 208000022873 Ocular disease Diseases 0.000 claims description 6
- 238000004500 asepsis Methods 0.000 claims description 2
- 230000002441 reversible effect Effects 0.000 claims description 2
- 238000004513 sizing Methods 0.000 claims description 2
- 238000002347 injection Methods 0.000 abstract description 5
- 239000007924 injection Substances 0.000 abstract description 5
- 238000007789 sealing Methods 0.000 description 20
- 230000001954 sterilising effect Effects 0.000 description 16
- 239000000463 material Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- 208000004644 retinal vein occlusion Diseases 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 6
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000005538 encapsulation Methods 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 108010081667 aflibercept Proteins 0.000 description 5
- 201000005111 ocular hyperemia Diseases 0.000 description 5
- 229960003876 ranibizumab Drugs 0.000 description 5
- 208000005590 Choroidal Neovascularization Diseases 0.000 description 4
- 206010060823 Choroidal neovascularisation Diseases 0.000 description 4
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- 206010073286 Pathologic myopia Diseases 0.000 description 4
- 239000005557 antagonist Substances 0.000 description 4
- 201000011190 diabetic macular edema Diseases 0.000 description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 229940051306 eylea Drugs 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229940076783 lucentis Drugs 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 206010012689 Diabetic retinopathy Diseases 0.000 description 2
- 239000003798 L01XE11 - Pazopanib Substances 0.000 description 2
- 208000001344 Macular Edema Diseases 0.000 description 2
- 206010025415 Macular oedema Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 206010038934 Retinopathy proliferative Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940120638 avastin Drugs 0.000 description 2
- 229960000397 bevacizumab Drugs 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 201000010230 macular retinal edema Diseases 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- CUIHSIWYWATEQL-UHFFFAOYSA-N pazopanib Chemical compound C1=CC2=C(C)N(C)N=C2C=C1N(C)C(N=1)=CC=NC=1NC1=CC=C(C)C(S(N)(=O)=O)=C1 CUIHSIWYWATEQL-UHFFFAOYSA-N 0.000 description 2
- 229960000639 pazopanib Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00736—Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/001—Apparatus specially adapted for cleaning or sterilising syringes or needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31513—Piston constructions to improve sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3117—Means preventing contamination of the medicament compartment of a syringe
- A61M2005/3118—Means preventing contamination of the medicament compartment of a syringe via the distal end of a syringe, i.e. syringe end for mounting a needle cannula
- A61M2005/312—Means preventing contamination of the medicament compartment of a syringe via the distal end of a syringe, i.e. syringe end for mounting a needle cannula comprising sealing means, e.g. severable caps, to be removed prior to injection by, e.g. tearing or twisting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
- A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0612—Eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Surgery (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
本发明提供一种用于眼部注射的注射器。该注射器包括主体、塞子及活塞。该主体包括在出口端处的出口且该塞子配置于该主体内,使得该塞子的前表面及该主体界定一可变容积腔,流体可通过该出口而从该可变容积腔排出。该柱塞包括在第一端处的柱塞接触表面和延伸于该柱塞接触表面与后部部分之间的杆。该柱塞接触表面经配置以接触该塞子但不与该塞子耦合,使得该柱塞可用于迫使该塞子朝向该主体的出口端移动以减小该可变容积腔的容积,但无法用于使该塞子向远离该出口端的方向移动。
Description
技术领域
本发明涉及一种注射器,尤其是一种小容积注射器,例如适合于眼部注射的一种注射器。本发明还提供一种组装该注射器的方法。
现有技术
诸多药剂通过注射器来输送给病人,使用者可以分配来自该注射器的药剂。若药剂是通过注射器来输送给病人,则通常需要该病人或看护者能够注射药剂。为使病人安全及药剂完整,重要的是注射器及其内含物需完全无菌以避免病人感染或其他风险。可藉由最终灭菌而实现灭菌,其中使用高温或灭菌气体来使通常已位于相关联封装中的组装产品无菌。
对于小容积注射器(例如用于眼部注射的注射器,其中意欲注射小于约0.1毫升的液体),灭菌可造成未必与较大的注射器相关的困难。注射器内部或外部的压力变化可导致注射器的部件不可预测地移动,其会改变密封特性且潜在地损及无菌性。注射器的不正确处置(包含组装)亦可造成产品无菌的风险。
发明内容
本发明提供一种注射器,该注射器包括主体、塞子及柱塞,该主体包括在出口端处的出口且配置于该主体内的塞子,使得该塞子的前表面及该主体形成一可变容积腔,流体可通过该出口从该可变容积腔排出,该柱塞包括在第一端处的柱塞接触表面及延伸于该柱塞接触表面与后部部分之间的杆,该柱塞接触表面经配置以接触该塞子但不与该塞子耦合,使得该柱塞可用于迫使该塞子朝向该主体的该出口端移动,以减小该可变容积腔的容积,但无法使该塞子向远离该出口端的方向移动。
提供不与塞子耦合的柱塞,能减小由于不正确处置注射器的可能性,此系因为柱塞可自注射器撤回且不移动塞子使其远离出口端。这防止了使用者非有意地移动柱塞(且因此移动连接至柱塞的塞子)和防止导致非无菌空气(或其他流体)被汲取至注射器中,或防止导致塞子移至非无菌区域。亦已发现,使用例如螺旋动作或推入配合动作来在组装期间产生柱塞与塞子的连接会以不可预测的方式扭曲塞子从而会损害最终产品的密封和/或无菌,或会增加可变容积腔中的压力从而可导致流体从出口端泄漏。注射器的主体可以是实质上的圆柱形壳体,或可包含具有非圆形外部形状的实质上的圆柱形孔。主体出口端包含出口,随着可变容积腔的容积减小,位于该腔内的流体可通过该出口而排出。该出口可包括来自出口端的突出部,具有比可变容积腔直径更小的直径的通道延伸穿过该突出部。该出口可通过例如鲁尔锁定(luer lock)式连接调整,以连接至针头或其他附件(诸如能够密封可变容积腔的密封装置),但可经操作或移除来开封可变腔,且允许注射器与另一附件诸如针头连接。此连接可直接形成于注射器与附件之间或经由密封装置而形成。主体沿第一轴自出口端延伸至后端。
主体可由塑性材料、玻璃或任何其他适合的材料制成,且可包含其表面上的标记,以用作注射导件。
塞子可由橡胶、硅或其他适合的弹性可变形材料制成。塞子藉在可变容积腔的后部设置有流体密封而提供密封功能,其亦提供无菌密封。塞子可是实质上的圆柱形且塞子可包含围绕塞子外表面的一个或多个圆周肋条,塞子及肋条的尺寸大小使得该肋条与注射器主体的内部表面形成实质上的流体密封。塞子的前表面可呈任何适合的形状,例如实质上呈平面或实质上呈锥形。塞子可实质上为实心的或可包含凹槽。塞子的后表面可包含实质上中央凹槽,其可在不损及塞子的密封功能的条件下呈任何形状。该中央凹槽可实质上呈圆柱形或该中央凹槽可包含具有一个第一直径的初始孔,该初始孔自后表面引导进入塞子且至具有一个第二直径的内凹槽,该第二直径大于该第一直径。此中央凹槽可以任何已知的方式将柱塞连接至使用搭扣配合特征的塞子。此设计允许使用实质上标准的塞子设计且此可减少注射器的部件成本。亦应注意,自塞子的中央部分移除材料(其中视情况无需塞子起要求的作用)以减轻塞子重量且减少制造塞子所需的材料数量。塞子可相对于穿过塞子的轴呈实质上可旋转地对称。
柱塞包括柱塞接触表面,且自该柱塞接触表面起延伸,杆自该柱塞接触表面延伸至后部部分。该后部部分可包含经调适以在注射事件期间由使用者接触的使用者接触部分。该使用者接触部分可包括实质上的圆盘形部分,该圆盘的半径实质上垂直于该杆的延伸轴。该使用者接触部分可呈任何适合形状。该杆的延伸杆可为第一轴或可实质上与第一轴平行。
柱塞接触表面经调适以与塞子的后表面接触,但不耦合至塞子的后表面。柱塞接触表面可实质上呈平面且可实质上呈圆形。柱塞接触表面可实质上呈圆形,其具有比主体内径小的外径。柱塞接触表面的直径可实质上等于与柱塞接触表面接触的塞子后表面的直径。柱塞接触表面可经调适以呈现相对于塞子后表面做实质上可旋转对称的表面,因为这样可在使用期间向塞子提供可重复且均匀分布的力以有助于防止其扭曲。柱塞接触表面可不呈平面,且可包括环形接触表面以在其外边缘或外边缘邻近处接触塞子。柱塞接触表面可包括自柱塞杆延伸以与塞子接触的若干个臂。在上述或其他实施例之一中,柱塞接触表面可实质上可旋转地对称。
杆可具有圆或交叉形横截面。交叉形横截面可由沿杆的至少部分延伸的肋条形成。该肋条可实质上与杆的延伸轴平行延伸。该交叉形横截面提供刚性至杆且不显著增大制造复杂性。
杆可由任何适合材料或材料的组合制成,且在一实施例中由塑性材料制成。杆可在预期使用条件下实质上具刚性。虽然在大体积制造的产品中无法避免柱塞中材料具有的一些挠曲,但有利的是杆不会在使用期间显著挠曲(对于低容积的准确注射而言尤其如此),此系因为任何挠曲会导致不可预测的剂量结果。
注射器可包含配置于在主体后部部分处的托架(backstop)。该托架可自注射器移除。若注射器主体包含在与出口端相对的端部处的终端法兰,则该托架可设置成以将主体的终端法兰实质上夹在其中间,此系因为可防止该托架沿平行于第一轴的方向移动。
杆可包括至少一个远离出口端方向的杆凸肩且托架可包含朝向出口端方向的托架凸肩,该托架凸肩与该杆凸肩合作以在该托架凸肩与该杆凸肩接触时实质上防止杆移动远离出口端。限制远离出口端的杆的移动可有助于在最终灭菌操作或其他操作(其中可变容积腔内或该腔外之压力可改变)期间维持无菌性。在此等操作期间,截留于可变容积腔内的任何气体或可形成于可变容积腔内的液体中的气泡可改变容积且藉此导致塞子移动。塞子远离出口的移动可导致由塞子产生的无菌区被破坏。此对于低容积注射器尤其重要,其中组件尺寸的公差更低及塞子的挠性更小。如本文中所使用,术语“无菌区”用于意指由塞子密封以防止自注射器的任一端进入注射器内的区域。此可为最靠近出口的塞子的密封件(例如圆周脊)与最远离出口的塞子的密封件(例如圆周脊)之间的区域。此两个密封件之间的距离界定为塞子的无菌区,此系因为塞子在无菌环境中安装于注射器圆筒中。
如上文所提及,最终灭菌程序可用于使整个对象无菌且此程序可使用任何一已知程序,诸如环氧乙烷或过氧化氢灭菌程序。
塞子上包含的一个或多个圆周肋条可改变使塞子自一静止位置移动所需的力且也可改变塞子的密封性。为进一步促进在上文所提及操作期间无菌性的维持,塞子可包括至少一个前圆周肋条及一个后圆周肋条且所述肋条可沿顺着第一轴的方向间隔达至少3毫米、至少3.5毫米、至少3.75毫米或4毫米或4毫米以上。一个或多个额外肋条(例如2个、3个、4个或5个额外肋条,或1个至10个、2个至8个、3个至6个或4个至5个之间的额外肋条)可配置于该前肋条与该后肋条之间。在一实施例中,总计存在三个圆周肋条。
具有增强无菌区的塞子亦可在最终灭菌程序期间给可注射药剂提供保护。一些药剂(例如生物药剂)会因暴露于环氧乙烷而受损。塞子上设置有更多肋条或前肋条与后肋条之间的距离更大可减少药剂对灭菌剂潜在的暴露。
杆凸肩可配置于杆的外径内,或可配置于杆的外径外。若提供延伸超过杆的外径但仍配合于主体内的凸肩,则该凸肩可藉由减少杆垂直于第一轴的移动而有助于稳定杆在主体内的移动。杆凸肩可包括形成杆上组件的任何适合凸肩,但在一实施例中,杆凸肩包括杆上的实质上圆盘形部分。
在注射器的一个实施例中,当配置有与塞子接触的柱塞接触表面且可变容积腔处于其所欲的最大容积时,杆凸肩与托架凸肩之间存在不大于约2毫米的空隙。在一些实施例中,存在小于约1.5毫米的空隙,且在一些实施例中,存在小于约1毫米的空隙。此距离经选择以实质上限制或防止塞子过度向后(远离出口端)移动。
在一实施例中,可变容积腔具有大于5毫米或6毫米及小于3毫米或4毫米的内径。该内径可介于3毫米至6毫米之间或介于4毫米至5毫米之间。在另一实施例中,注射器经定尺寸以便具有约0.25毫升至约0.75毫升之间或0.4毫升至0.6毫升之间容积的标称最大填充容积。注射器主体的长度可小于70毫米、小于60毫米或小于50毫米。在一实施例中,注射器主体的长度介于45毫米至50毫米之间,该内径介于4毫米至5毫米之间,及该填充容积介于0.1毫升液体至0.3毫升液体之间。
在一实施例中,注射器适合于眼部注射,且因而具有适合的小容积。注射器可适用于眼部注射。注射器亦可不含硅(silicone free),或实质上不含硅,或可包括一低含量的硅作为润滑剂。在一实施例中,注射器可符合USP789。
注射器的可变容积腔可填充有任何适合可注射液体或药剂,例如可注射药剂。在一实施例中,可变容积腔填充有可注射药剂,其包括适合于治疗眼部疾病的活性剂。此眼部疾病的实例包含脉络膜新生血管、年龄相关的黄斑变性(湿性及干性两者)、视网膜静脉阻塞(RVO)继发的黄斑水肿(其包含分支RVO(bRVO)及中央RVO(cRVO)两者)、病理性近视(PM)继发的脉络膜新生血管、糖尿病性黄斑水肿(DME)、糖尿病性视网膜病变及增殖性视网膜病变。在一实施例中,该药剂包括生物活性剂。该生物活性剂可为抗体(或其碎片)或非抗体蛋白质。在一实施例中,该药剂包括VEGF拮抗剂。适合的VEGF拮抗剂包含兰尼单抗(LucentisTM)、贝伐单抗(AvastinTM)、阿柏西普(EyleaTM,亦称为VEGF-Trap Eye)、康柏西普(购自成都康弘生物科技有限公司的KH902,在WO2005/121176中被描述为FP3,该专利申请的全文以引用的方式并入本文中)及相关糖型KH906或帕唑帕尼(购自GlaxoSmithKline)。
在一实施例中,注射器填充有约0.01毫升至约2毫升之间(例如约0.05毫升至约1毫升之间、约0.1毫升至约0.5毫升之间)的可注射药剂。当然,为考虑归因于注射器及针头内的“死腔”的损耗量,注射器通常填充有比待给予病人所要剂量要多的剂量。因此,在一实施例中,注射器填充有约0.01毫升至约2毫升之间(例如约0.05毫升至约1毫升之间、约0.1毫升至约0.5毫米之间)的剂量容积(即,意欲输送至病人的药剂容积)的可注射药剂。例如,对于Lucentis,该剂量容积为0.05毫升或0.03毫升(0.5毫克或0.3毫克)的10毫克/毫升可注射药剂溶液;对于Eylea,该剂量容积为0.05毫升的40毫克/毫升可注射药剂溶液。
如上文所提及,当注射器含有药剂溶液时,出口可经可逆密封以维持药剂的无菌性。可通过使用现有技术中已知的密封装置来实现此密封。例如可购自Vetter Pharma International GmbH的OVSTM系统。出口的密封应使得可变容积腔的内含物的该无菌性可被维持,直至移动塞子以破坏无菌密封或开封出口。
若提供不与塞子耦合的柱塞,则新的组装方法变为可行且本发明因此进一步提供组装注射器的方法,该方法包括以下步骤:
i)提供主体及塞子,该主体包括一个在出口端的出口且该塞子配置于该主体内,使得该塞子的前表面及该主体界定一个可变容积腔,流体可透过该出口且从该可变容积腔排出,该出口经可释放地密封且该可变容积腔含有药剂;及
ii)提供柱塞,该柱塞包括一个在第一端处的柱塞接触表面及延伸于该柱塞接触表面与后部部分之间的杆且将该柱塞接触表面及至少部分该柱塞配置于该主体内并且不将该柱塞耦合至该塞子。
该方法可进一步包括额外步骤(步骤iii)):填充注射器的可变容积腔,该可变容积腔可填充有任何适合可注射药剂。在一实施例中,可变容积腔填充有适合于治疗眼部疾病的可注射药剂。此眼部疾病的实例包含脉络膜新生血管、年龄相关的黄斑变性(湿性及干性两者)、视网膜静脉阻塞(RVO)继发的黄斑水肿(其包含分支RVO(bRVO)及中央RVO(cRVO)两者)、病理性近视(PM)继发的脉络膜新生血管、糖尿病性黄斑水肿(DME)、糖尿病性视网膜病变及增殖性视网膜病变。在一实施例中,该药剂包括生物活性剂。该生物活性剂可为抗体(或其碎片)或非抗体蛋白质。在一实施例中,该药剂包括VEGF拮抗剂。适合的VEGF拮抗剂包含兰尼单抗(LucentisTM)、贝伐单抗(AvastinTM)、阿柏西普(EyleaTM,亦称为VEGF-Trap Eye)、康柏西普(购自成都康弘生物科技有限公司的KH902,在WO2005/121176中被描述为FP3,该专利申请的全文以引用的方式并入本文中)及相关糖型KH906或帕唑帕尼(购自GlaxoSmithKline)。
应注意,可依任一顺序实施以上步骤ii)及iii)。因此,方法可依序包括步骤i)、ii)、iii)或步骤i)、iii)、ii)或步骤iii)、i)、ii)。
方法可进一步包括步骤iv):将经组装注射器封装于实质上密封的封装中。方法可进一步包括封装之后的最终灭菌步骤(步骤v))。该最终灭菌步骤可包括已知技术,诸如环氧乙烷灭菌或过氧化氢灭菌。
本发明亦提供一种密封封装,其含有实质上如本文中所描述的无菌预填充注射器。
若杆包括如上文所描述的杆凸肩且注射器包含如所描述的可移除托架,则该托架可在柱塞已配置于主体中之后耦合至注射器主体且该杆凸肩配置于出口端与该托架凸肩之间。为确保该杆凸肩配置于出口端与该托架凸肩之间,当该托架耦合至装置时,避免用于在将该托架耦合至注射器之后使该杆凸肩能够移动通过该托架凸肩的复杂机构。
在一实施例中,在无菌或实质上无菌环境中实施步骤i)及iii)。在填充步骤与密封成封装之最终组装之间的某一点处,自该无菌或实质上无菌环境移除注射器。接着,可对经封装产品进行最终灭菌步骤。
在方法的实施例中,柱塞杆落入至注射器主体中。此方法简单操作且利用重力而非任何自动化组装设备。此方法是可行的,因为无需操纵或迫使杆与塞子耦合。
本发明亦提供一种适合于用在上文所描述的注射器或方法中的柱塞。
应了解,在本说明书及以下申请专利权力要求中,若全文无另外要求,则用语“包括”或其变体隐含包含所陈述的整体、或步骤、或一组整体或步骤。术语“包括”涵盖“包含”以及“组成”,例如,“包括”X的组合物可仅由X组成或可包含一些额外项(例如X+Y)。亦应了解,若非实体上不可能的,则可单独使用与一个实施例描述相关的特征,或可与相同实施例或一个或多个其他实施例描述相关的一个或多个特征组合地使用与实施例描述相关的特征。与数值x相关之术语“约”系可选的且意指(例如)x+/-10%。
附图简要说明
参考附图,现将仅以举例方式进一步描述本发明,其中:
图1为注射器的侧视图;
图2为注射器的俯视图的横截面;
图3为柱塞的视图;
图4为穿过柱塞的横截面;
图5为塞子;及
图6为组装程序的流程图。
具体实施方式
图1为注射器1的侧视图,其包括主体2、柱塞4、托架6及密封装置8。
图2为自图1上方穿过注射器1的横截面。注射器1适合于用在眼部注射中。注射器1包括主体2、塞子10及柱塞4。注射器1沿第一轴A延伸。主体2包括在出口端14处的出口12且塞子10配置于主体2内,使得塞子10的前表面16及主体2界定一个可变容积腔18。可变容积腔18含有包括兰尼单抗的可注射药剂20。可藉由使塞子10朝向出口端14移动以此减小可变容积腔18的容积并透过出口12排出可注射流体20。柱塞4包括在第一端24处的柱塞接触表面22及延伸于柱塞接触表面22与后部部分25之间的杆26。柱塞接触表面22经配置以接触塞子10但不耦合至塞子10,使得柱塞4可用于使塞子10朝向主体2的出口端14移动。此移动减小可变容积腔18的容积且导致其内的流体透过出口排出。然而,由于柱塞4不耦合至塞子10,所以无法使用柱塞4来使塞子10向远离出口端14的方向移动。
托架6藉由耦合至主体2的终端法兰28而附接至主体2。托架6包含夹层部分30,其经调适以将主体2的终端法兰28的至少部分实质上夹在其中间。托架6经调适以藉由使托架6的一侧敞开使得托架6可配合至注射器2从而自侧面耦合至主体2。
主体2界定具有孔半径的实质上圆柱形孔36。杆26包括远离出口端14方向的杆凸肩32。杆凸肩32自第一轴A延伸至杆凸肩半径,其使得杆凸肩32略小于该孔半径以使凸肩配合于孔36内。托架6包含朝向出口端14方向的托架凸肩34。凸肩32、34经配置以在托架凸肩34与杆凸肩32接触时一起实质上防止杆26向远离出口端14的方向移动。托架凸肩34自该孔半径的外部延伸至小于杆凸肩的半径,使得杆凸肩32无法藉由沿第一轴A移动而通过托架凸肩34。在此情况中,杆凸肩32实质上呈圆盘形、或环形、或经塑形且托架凸肩34包含围绕主体2的后端38的弧形。
托架6亦包含两个指状突出部40,其等沿实质上垂直于第一轴A的远离主体2的相反方向延伸以促进注射器1在使用期间的手动处置。
在此实例中,注射器包括0.5毫升的主体2,其为具有约0.5毫升的理论最大填充容积的主体,该主体填充有约0.1毫升至约0.3毫升之间的可注射药剂20,该可注射药剂包括含有兰尼单抗的10毫克/毫升可注射溶液。注射器主体2具有约4.5毫米至约4.8毫米之间的内径、约45毫米至约50毫米之间的长度。
将参考后图而更详细地描述柱塞4及塞子10。
图3为图1的柱塞4的透视图,其展示在柱塞4第一端24处的柱塞接触表面22。杆26自第一端24延伸至后部部分25。后部部分25包含圆盘形法兰42以促进用户处置装置。法兰42提供比杆26的裸端大的表面区域以供用户接触。
杆26包括沿杆26延伸的肋条44,该肋条形成杆26的交叉形横截面,如后图中更详细所展示。杆26包括圆盘形部分46,圆盘形部分46径向延伸超出肋条44,并且也形成杆凸肩32。
肋条44可实质上为实心的或可包含间隙48。圆盘形部分46可为实心的或可包含间隙50。为了无菌或其他目的,空隙48、50可视情况用于促进主体2内的气体流动。
图4为穿过注射器主体2及杆26的横截面。杆26包含四个纵向肋条44且所述肋条之间的角度为90°。
图5为塞子10的详细视图,其展示锥形前表面16及围绕实质上圆柱形主体58的三个圆周肋条52、54、56。第一肋条52与最后肋条56之间的轴向间隙为约3毫米。塞子10的后表面60包含实质上中央凹槽62。中央凹槽62包含具有第一直径的初始孔64。初始孔64自后表面60引导进入塞子10至具有第二直径的内凹槽66处,该第二直径大于该第一直径。
图6为用于组装注射器1的流程图。在步骤1中,提供预填充主体2。预填充主体2包括填充有可注射药剂20(其包括兰尼单抗)的主体2,但可另外或代以使用其他药剂,或可使用安慰剂溶液。塞子10配置于主体2中以形成可变容积腔18且出口12由密封装置8密封。
在步骤2中,柱塞4配置于主体2中。在一实施例中,柱塞4落入至主体2中。此可仅藉由重力,或可使用机器或人力来将柱塞放置至主体2中,且接着定向主体使得柱塞4在主体2中降落,直至柱塞接触表面22与塞子10接触。
在步骤3中,托架6耦合至主体的终端法兰28。托架6及杆经配置,使得杆凸肩32位于主体的出口端与托架凸肩34之间。
在步骤4中,将注射器密封至封装中,且在步骤5中,在最终灭菌程序中使该封装及其内含物无菌。该最终灭菌程序可使用已知程序,诸如环氧乙烷或过氧化氢灭菌程序。
应了解,以上已仅以举例方式描述本发明且可在不背离专利申请权力要求的范围的情况下对细节作出修改。
Claims (17)
1.一种注射器,所述注射器包括主体、塞子及柱塞,所述主体包括在出口端处的出口和配置于所述主体内的所述塞子,使得所述塞子的前表面及所述主体界定一可变容积腔,流体可通过所述出口且自所述可变容积腔排出,所述柱塞包括在第一端处的柱塞接触表面及延伸于所述柱塞接触表面与后部部分之间的杆,所述柱塞接触表面经配置以接触所述塞子但不与之耦合,使得所述柱塞可用于迫使所述塞子朝向所述主体的出口端移动以减小所述可变容积腔的容积,但无法用于使所述塞子向远离所述出口端的方向移动。
2.如权利要求1所述的注射器,其中所述柱塞接触表面为实质上平面圆盘且所述柱塞接触表面接触所述塞子的后表面。
3.如权利要求1或2之一所述的注射器,其中所述杆包括至少一个远离所述出口端的杆凸肩,且所述注射器包含配置于在所述主体的后部部分处的托架,所述托架包含朝向所述出口端的托架凸肩,所述托架凸肩与所述杆凸肩合作以在当所述托架凸肩与所述杆凸肩接触时实质上防止所述柱塞杆向远离所述出口端的方向移动。
4.如上述任何权利要求之一所述的注射器,其中所述杆凸肩配置于所述杆的外径内。
5.如上述任何权利要求之一所述的注射器,其中所述杆凸肩包括所述杆上的实质上圆盘形部分。
6.如权利要求3至5之一所述的注射器,其中所述托架可将从所述注射器移除。
7.如权利要求6所述的注射器,其中所述托架配置成以将所述主体的终端法兰实质上夹在中间。
8.如权利要求3至7之一所述的注射器,其中当所述柱塞接触表面与所述塞子接触且所述可变容积腔处于其所欲的最大容积时,所述杆凸肩与所述托架凸肩之间存在不超过2毫米的空隙。
9.如上述任何权利要求之一所述的注射器,其中所述可变容积腔具有4毫米至5毫米之间的内径。
10.如上述任何权利要求之一所述的注射器,其中所述注射器经定尺寸以便具有0.4毫升至0.6毫升之间的标称最大容积。
11.如上述任何权利要求之一所述的注射器,其中所述注射器为眼用注射器且所述可变容积腔填充有可注射药剂,所述可注射药剂包括适合于治疗眼部疾病的药剂,且所述出口为可逆密封。
12.一种注射器包装,其包括密封封装及如前述权力要求中任一项的无菌注射器。
13.一种组装注射器的方法,所述方法包括以下步骤:
i)提供主体及塞子,所述主体包括在出口端处的出口和配置于所述主体内的所述塞子,使得所述塞子的前表面及所述主体界定一可变容积腔,流体可通过所述出口从所述可变容积腔排出,所述出口被可释放地密封且所述可变容积腔含有药剂;及
ii)提供柱塞,所述柱塞包括在第一端处的柱塞接触表面及延伸于所述柱塞接触表面与后部部分之间的杆,且将所述柱塞接触表面及至少部分的所述柱塞配置于所述主体内并且不将所述柱塞耦合至所述塞子。
14.如权利要求13所述的方法,其中所述可变容积腔含有可注射药剂,所述可注射药剂包括适合于治疗眼部疾病的药剂。
15.如权利要求13或14之一所述的方法,其中所述杆包括至少一杆远离所述柱塞接触表面的凸肩且提供托架,所述托架包含朝向所述出口端的托架凸肩,所述托架在所述柱塞配置于所述主体中之后耦合至所述注射器主体,且所述杆凸肩配置于所述出口端与所述托架凸肩之间。
16.如权利要求13至15之一所述的方法,其中所述柱塞杆落入至所述注射器主体中。
17.一种柱塞,其适合于用在如权利要求1至11中任何一项所述的注射器或如权利要求13至16之一所述的方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12170628.7 | 2012-06-01 | ||
EP12170628 | 2012-06-01 | ||
PCT/EP2013/061215 WO2013178771A1 (en) | 2012-06-01 | 2013-05-30 | Syringe |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104780906A true CN104780906A (zh) | 2015-07-15 |
Family
ID=48577723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380028946.2A Pending CN104780906A (zh) | 2012-06-01 | 2013-05-30 | 注射器 |
Country Status (37)
Country | Link |
---|---|
US (9) | US20150105734A1 (zh) |
EP (5) | EP2854762A1 (zh) |
JP (8) | JP6781546B2 (zh) |
KR (5) | KR102288287B1 (zh) |
CN (1) | CN104780906A (zh) |
AR (1) | AR091817A1 (zh) |
AU (1) | AU2013269594C1 (zh) |
BR (1) | BR112014029795B1 (zh) |
CA (2) | CA2875193A1 (zh) |
CL (1) | CL2014003251A1 (zh) |
CO (1) | CO7141462A2 (zh) |
CY (3) | CY1124375T1 (zh) |
DE (1) | DE202013012825U1 (zh) |
DK (4) | DK3536310T3 (zh) |
EA (1) | EA033161B1 (zh) |
ES (4) | ES2881196T3 (zh) |
GT (1) | GT201400279A (zh) |
HK (1) | HK1202816A1 (zh) |
HR (3) | HRP20220558T1 (zh) |
HU (2) | HUE055994T2 (zh) |
IL (3) | IL235882B (zh) |
IN (1) | IN2014DN09689A (zh) |
LT (3) | LT3536310T (zh) |
MA (2) | MA42648B1 (zh) |
MX (2) | MX2014014722A (zh) |
MY (1) | MY165727A (zh) |
NZ (1) | NZ702313A (zh) |
PE (1) | PE20142396A1 (zh) |
PH (1) | PH12014502675A1 (zh) |
PL (4) | PL3679922T3 (zh) |
PT (4) | PT3536310T (zh) |
SG (2) | SG11201407241QA (zh) |
SI (4) | SI3858405T1 (zh) |
TN (1) | TN2014000471A1 (zh) |
TW (1) | TW201402165A (zh) |
WO (1) | WO2013178771A1 (zh) |
ZA (1) | ZA201408019B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108290004A (zh) * | 2015-11-18 | 2018-07-17 | 福尔密孔股份公司 | 含有vegf拮抗剂的预填充塑料注射器 |
CN109475429A (zh) * | 2016-06-30 | 2019-03-15 | 东佩制药股份公司 | 容量控制滴管 |
CN110312541A (zh) * | 2017-02-17 | 2019-10-08 | 贝克顿·迪金森公司 | 带有塞子引导件的注射器和柱塞杆 |
CN111148539A (zh) * | 2017-09-29 | 2020-05-12 | 豪夫迈·罗氏有限公司 | 预填充式注射器和制备预填充式注射器的方法 |
CN112188906A (zh) * | 2018-05-24 | 2021-01-05 | 诺华股份有限公司 | 药物自动输送装置 |
CN112657020B (zh) * | 2016-01-15 | 2022-09-27 | W.L.戈尔及同仁股份有限公司 | 注射器柱塞组件 |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11624115B2 (en) | 2010-05-12 | 2023-04-11 | Sio2 Medical Products, Inc. | Syringe with PECVD lubrication |
US9878101B2 (en) | 2010-11-12 | 2018-01-30 | Sio2 Medical Products, Inc. | Cyclic olefin polymer vessels and vessel coating methods |
US11116695B2 (en) | 2011-11-11 | 2021-09-14 | Sio2 Medical Products, Inc. | Blood sample collection tube |
JP6095678B2 (ja) | 2011-11-11 | 2017-03-15 | エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド | 薬剤パッケージ用の不動態化、pH保護又は滑性皮膜、被覆プロセス及び装置 |
HRP20220558T1 (hr) | 2012-06-01 | 2022-06-10 | Novartis Ag | Štrcaljka |
JOP20200175A1 (ar) | 2012-07-03 | 2017-06-16 | Novartis Ag | حقنة |
US9764093B2 (en) | 2012-11-30 | 2017-09-19 | Sio2 Medical Products, Inc. | Controlling the uniformity of PECVD deposition |
EP4234753A3 (en) | 2013-03-11 | 2023-11-01 | SiO2 Medical Products, Inc. | Coated packaging |
WO2015148471A1 (en) | 2014-03-28 | 2015-10-01 | Sio2 Medical Products, Inc. | Antistatic coatings for plastic vessels |
DE102014006323B4 (de) | 2014-04-30 | 2024-05-29 | Gerresheimer Regensburg Gmbh | Vorgefüllte Spritze mit Wiederverwendungsschutz |
JP6802069B2 (ja) * | 2014-05-12 | 2020-12-16 | フォーマイコン アーゲーFormycon Ag | Vegf拮抗薬を収容したプレフィルドプラスチックシリンジ |
US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
MA41906A (fr) | 2015-04-10 | 2018-02-13 | Dompe Farm Spa | Dispositif de distribution de gouttes oculaires |
WO2017011895A1 (en) * | 2015-07-23 | 2017-01-26 | Luc Magne | Shroud for a dental syringe and combination thereof |
US10800597B2 (en) * | 2015-09-11 | 2020-10-13 | New Product Development Concepts Llc | Telescoping syringe with one-way valve |
WO2017087871A1 (en) * | 2015-11-18 | 2017-05-26 | Sio2 Medical Products, Inc. | Pharmaceutical package for ophthalmic formulations |
RU2744860C2 (ru) | 2015-12-30 | 2021-03-16 | Кодиак Сайенсиз Инк. | Антитела и их конъюгаты |
RU2709154C1 (ru) * | 2016-04-08 | 2019-12-16 | Аллерган, Инк. | Аспирационно-инъекционное устройство |
US11419985B2 (en) * | 2016-09-12 | 2022-08-23 | Min Wei | Medication injection device |
US10799639B2 (en) * | 2017-03-03 | 2020-10-13 | Min Wei | Syringe type medication delivery device |
KR102535910B1 (ko) | 2017-03-27 | 2023-05-25 | 리제너론 파아마슈티컬스, 인크. | 살균 방법 |
WO2018180458A1 (ja) * | 2017-03-31 | 2018-10-04 | 武田薬品工業株式会社 | シリンジ |
US10898649B2 (en) | 2017-05-05 | 2021-01-26 | Alcon Inc. | Syringe |
KR102602601B1 (ko) | 2017-12-13 | 2023-11-16 | 리제너론 파아마슈티컬스, 인크. | 정밀 도즈 전달을 위한 장치 및 방법 |
EP3735286A4 (en) | 2018-01-03 | 2021-03-03 | Irenix Medical, Inc. | DEVICES FOR DELIVERY OF THERAPEUTIC AGENTS WITH INTEGRATED PAIN RELIEF, AND THEIR METHODS FOR USE |
EP3746156B1 (en) * | 2018-02-02 | 2023-12-06 | F. Hoffmann-La Roche AG | Prefilled syringe and method of sterilizing a prefilled syringe |
CA3092588A1 (en) | 2018-03-02 | 2019-09-06 | Kodiak Sciences Inc. | Il-6 antibodies and fusion constructs and conjugates thereof |
US20210128840A1 (en) * | 2018-04-09 | 2021-05-06 | Sio2 Medical Products, Inc. | Stretchable plunger assemblies |
US11103552B2 (en) | 2018-05-10 | 2021-08-31 | Regeneron Pharmaceuticals, Inc. | High concentration VEGF receptor fusion protein containing formulations |
US20210260300A1 (en) * | 2018-06-01 | 2021-08-26 | Sun Pharma Advanced Research Company Limited | An injection device |
JP2019217105A (ja) | 2018-06-21 | 2019-12-26 | 株式会社松風 | 注入器 |
EP3969081A1 (en) * | 2019-05-17 | 2022-03-23 | West Pharmaceutical Services, Inc. | Adaptive primary packaging for therapeutic solutions |
SG11202112640PA (en) | 2019-06-05 | 2021-12-30 | Regeneron Pharma | Devices and methods for precision dose delivery |
USD920519S1 (en) * | 2019-06-28 | 2021-05-25 | Oertli-Instrumente Ag | Medical instrument for eye surgical purposes |
AU2020323937A1 (en) | 2019-07-29 | 2022-02-24 | Regeneron Pharmaceuticals, Inc. | Medical device packaging and related methods |
USD906102S1 (en) | 2019-07-29 | 2020-12-29 | Regeneron Pharmaceuticals, Inc. | Packaging |
JP2022546082A (ja) | 2019-09-03 | 2022-11-02 | アムジエン・インコーポレーテツド | 薬物送達のための注入デバイス及び注入デバイスのためのパッケージ |
US11912784B2 (en) | 2019-10-10 | 2024-02-27 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
JP2023505488A (ja) * | 2019-12-05 | 2023-02-09 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 注射器および気密性の試験方法 |
AU2020413912A1 (en) | 2019-12-27 | 2022-08-11 | Terumo Kabushiki Kaisha | Syringe-barrel grip, barrel assembly, and syringe |
WO2021192637A1 (ja) | 2020-03-24 | 2021-09-30 | テルモ株式会社 | 注射器バレル用グリップおよびバレル組立体ならびにシリンジ |
EP4153494A4 (en) * | 2020-05-21 | 2024-10-09 | Coherus Ophthalmology Llc | SYSTEMS AND METHODS FOR MANUFACTURING STERILE INJECTION DEVICES |
USD961376S1 (en) | 2020-07-29 | 2022-08-23 | Regeneron Pharmaceuticals, Inc. | Packaging |
USD961377S1 (en) | 2020-07-29 | 2022-08-23 | Regeneron Pharmaceuticals, Inc. | Packaging |
KR102720956B1 (ko) * | 2020-12-15 | 2024-10-24 | 삼천당제약주식회사 | 안과용 제형을 포함하는 시린지 |
WO2022217194A1 (en) * | 2021-04-06 | 2022-10-13 | Vitrean Inc. | A prefilled syringe containing a sterile ultraconcentrated hydrogel |
CA3235966A1 (en) * | 2021-11-29 | 2023-06-01 | Amgen Inc. | Plunger rod removal force method and fixture |
WO2023153535A1 (ko) * | 2022-02-09 | 2023-08-17 | 삼천당제약주식회사 | 안과용 제형을 포함하는 시린지 |
USD1047700S1 (en) | 2022-08-26 | 2024-10-22 | Regeneron Pharmaceuticals, Inc. | Packaging |
USD1035436S1 (en) | 2022-08-26 | 2024-07-16 | Regeneron Pharmaceuticals, Inc. | Packaging |
USD1042107S1 (en) | 2022-08-26 | 2024-09-17 | Regeneron Pharmaceuticals, Inc. | Packaging |
EP4389176A1 (en) | 2022-12-20 | 2024-06-26 | W. L. Gore & Associates, Inc. | Low insertion force syringe stoppers, assemblies, and associated methods |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5181918A (en) * | 1990-08-10 | 1993-01-26 | Thera Patent Gmbh & Co. Kg Gesellschaft Fuer Industrielle Schutzrechte | Granules syringe |
US20060293270A1 (en) * | 2005-06-22 | 2006-12-28 | Adamis Anthony P | Methods and compositions for treating ocular disorders |
WO2007035621A1 (en) * | 2005-09-16 | 2007-03-29 | (Osi) Eyetech, Inc. | Ophthalmic syringe |
DE19613035B4 (de) * | 1996-03-19 | 2007-12-13 | Ferring Gmbh | System mit einer Spritze und einem Griffstück |
CN201263820Y (zh) * | 2008-09-02 | 2009-07-01 | 甘肃成纪生物药业有限公司 | 双室卡式瓶粉针剂预灌装注射器 |
DE102008005938A1 (de) * | 2008-01-24 | 2009-07-30 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Vorgefüllte Spritze und Verfahren zum Verpacken einer Spritze |
CN102065939A (zh) * | 2008-06-17 | 2011-05-18 | 电气化学工业株式会社 | 注射器 |
Family Cites Families (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1704924A (en) * | 1925-09-05 | 1929-03-12 | Cook Lab Inc | Syringe cartridge |
US2236727A (en) * | 1939-01-07 | 1941-04-01 | Calbar Paint & Varnish Company | Plastic material dispenser |
US2602447A (en) | 1947-12-20 | 1952-07-08 | Kollsman Paul | Device for hypodermic injection |
US3148772A (en) * | 1962-09-18 | 1964-09-15 | Dentists Supply Co | Sterile surgical packaging |
US3248950A (en) | 1964-05-25 | 1966-05-03 | Dow Chemical Co | Stop mechanism for pipette filling device |
US3618603A (en) | 1969-01-29 | 1971-11-09 | Levenson M F | Syringe |
FR2348708A1 (fr) | 1976-04-23 | 1977-11-18 | Becton Dickinson France | Ampoule-seringue et son procede d'utilisation |
DE2629557B2 (de) | 1976-07-01 | 1980-05-14 | Paul E. Dr.Med. 8000 Muenchen Doerr | Einmai-Injektionsspritze |
US4507113A (en) | 1982-11-22 | 1985-03-26 | Derata Corporation | Hypodermic jet injector |
US4543093A (en) | 1982-12-20 | 1985-09-24 | Becton, Dickinson And Company | Variable sealing pressure plunger rod assembly |
JPH0747045B2 (ja) | 1986-10-15 | 1995-05-24 | 株式会社大協精工 | 積層した注射器用滑栓 |
WO1988010130A1 (en) | 1987-06-19 | 1988-12-29 | Terumo Kabushiki Kaisha | Medical instrument and production thereof |
JPH0534669Y2 (zh) | 1988-03-16 | 1993-09-02 | ||
JPH0725953Y2 (ja) * | 1988-03-17 | 1995-06-14 | 株式会社大協精工 | 注射器の滑栓 |
US4946441A (en) | 1988-07-21 | 1990-08-07 | Maurice Laderoute | Limited use hypodermic syringe |
GB2245173A (en) | 1989-06-30 | 1992-01-02 | Yiu Fai Leung | Single-use syringe |
US5173258A (en) | 1989-10-11 | 1992-12-22 | American Sterilizer Company | Recirculation, vapor and humidity control in a sealable enclosure |
JPH0666689A (ja) | 1991-01-23 | 1994-03-11 | Iseki & Co Ltd | 穀物乾燥調製施設における食味検査設備 |
WO1994013345A1 (en) | 1992-12-14 | 1994-06-23 | Mallinckrodt Medical, Inc. | Pre-filled, sterilized syringe and method of making |
US5380295A (en) | 1992-12-14 | 1995-01-10 | Mallinckrodt Medical, Inc. | Delivery apparatus with mechanism preventing rearward movement of a piston disposed therein |
JPH0666689U (ja) * | 1993-03-05 | 1994-09-20 | 浪華ゴム工業株式会社 | 注射器 |
JP3186422B2 (ja) | 1993-05-14 | 2001-07-11 | 武田薬品工業株式会社 | プラスチゾル |
US5405326A (en) | 1993-08-26 | 1995-04-11 | Habley Medical Technology Corporation | Disposable safety syringe with retractable shuttle for luer lock needle |
DE4332308C1 (de) | 1993-09-23 | 1994-09-29 | Heraeus Kulzer Gmbh | Spritze zum dosierten Abgeben von viskosen Werkstoffen, insbesondere von dentalen Werkstoffen |
US5795337A (en) * | 1994-02-14 | 1998-08-18 | Becton Dickinson And Company | Syringe assembly and syringe stopper |
US5597530A (en) | 1994-08-18 | 1997-01-28 | Abbott Laboratories | Process for prefilling and terminally sterilizing syringes |
US5688252A (en) | 1994-09-30 | 1997-11-18 | Takeda Chemical Industries, Ltd. | Syringe |
US5667495A (en) | 1995-04-21 | 1997-09-16 | Becton Dickinson France S.A. | Backstop device for a syringe |
US5607400A (en) | 1995-05-19 | 1997-03-04 | Becton, Dickinson And Company | Pre-fillable syringe and stopper assembly therefor |
US5607399A (en) | 1995-09-22 | 1997-03-04 | Becton, Dickinson And Company | Backstop device for a flangeless syringe |
JP2814982B2 (ja) | 1996-04-19 | 1998-10-27 | 日本電気株式会社 | テストデータ生成装置 |
JPH09308689A (ja) * | 1996-05-21 | 1997-12-02 | Nihon Medi Physics Co Ltd | 突起を有するプランジャーおよび注射器 |
DE19622283A1 (de) | 1996-05-23 | 1997-11-27 | Schering Ag | Verfahren zur terminalen Sterilisierung von befüllten Spritzen |
CA2286330C (en) | 1997-04-07 | 2008-06-10 | Genentech, Inc. | Anti-vegf antibodies |
JP3387775B2 (ja) | 1997-05-22 | 2003-03-17 | 株式会社大協精工 | 注射器用密封栓及びプレフィルド注射器 |
US6808706B1 (en) | 1997-10-15 | 2004-10-26 | Asaki Kasei Pharma Corporation | Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
US6228324B1 (en) | 1997-11-28 | 2001-05-08 | Seikagaku Corporation | Sterilizing method for medical sterilization packaging and injection pack |
JP3831505B2 (ja) * | 1997-12-26 | 2006-10-11 | 生化学工業株式会社 | 医療用滅菌包装における滅菌方法 |
EP1433705B1 (en) * | 1998-03-13 | 2015-07-22 | Becton Dickinson and Company | Method for manufacturing, filling and packaging medical containers |
US6200627B1 (en) | 1998-03-17 | 2001-03-13 | Becton, Dickinson And Company | Low silicone glass prefillable syringe |
CA2329707A1 (en) | 1998-04-30 | 1999-11-04 | Abbott Laboratories | Syringe assembly |
USD430015S (en) | 1998-06-11 | 2000-08-29 | Pharmacia & Upjohn Ab | Blister pack for a syringe |
JP2000014779A (ja) | 1998-07-02 | 2000-01-18 | Wada Kiyoutaro | プレフィールドシリンジ |
JP2001104480A (ja) | 1999-10-05 | 2001-04-17 | Daikyo Seiko Ltd | プラスチック製プレフィルド注射器の密封に使用するゴム製ピストン |
US20020193740A1 (en) | 1999-10-14 | 2002-12-19 | Alchas Paul G. | Method of intradermally injecting substances |
US20030032928A1 (en) | 2000-03-02 | 2003-02-13 | Morihiro Sudo | Prefilled syringe assembly |
US6608038B2 (en) | 2000-03-15 | 2003-08-19 | Novartis Ag | Methods and compositions for treatment of diabetes and related conditions via gene therapy |
JP2001340455A (ja) | 2000-05-31 | 2001-12-11 | Yoshino Kogyosho Co Ltd | シリンジ容器 |
JP4370045B2 (ja) * | 2000-06-21 | 2009-11-25 | 大成化工株式会社 | シリンジ |
JP4626064B2 (ja) | 2000-09-28 | 2011-02-02 | 生化学工業株式会社 | 注射器 |
JP2002177388A (ja) | 2000-12-15 | 2002-06-25 | Daikyo Seiko Ltd | 医薬・医療用既充填注射器 |
DE10103706A1 (de) | 2001-01-26 | 2002-08-14 | Aventis Behring Gmbh | Verwendung eines Hydrogenperoxid-Plasma-Sterilisationsverfahrens für die schonende Sterilisation temperaturempfindlicher Produkte |
JP2002241264A (ja) | 2001-02-19 | 2002-08-28 | Asahi Kasei Corp | エルカトニンのプレフィルドシリンジ製剤 |
US20020172615A1 (en) | 2001-03-08 | 2002-11-21 | Archie Woodworth | Apparatus for and method of manufacturing a prefilled sterile container |
DE10122959A1 (de) | 2001-05-11 | 2002-11-21 | West Pharm Serv Drug Res Ltd | Pharmazeutischer Spritzenkolben sowie Verfahren und Vorrichtung zu dessen Herstellung |
JP2003052819A (ja) | 2001-08-10 | 2003-02-25 | Seikagaku Kogyo Co Ltd | 薬剤充填注射器包装物およびその滅菌または殺菌方法 |
US6802828B2 (en) | 2001-11-23 | 2004-10-12 | Duoject Medical Systems, Inc. | System for filling and assembling pharmaceutical delivery devices |
EP1455870B1 (en) | 2001-12-06 | 2007-08-08 | Novo Nordisk A/S | A medical delivery system |
AU2002357520A1 (en) | 2001-12-27 | 2003-07-15 | Menicon Co., Ltd. | Cartridge syringe, cartridge and ophthalmologic syringe set equipped with the cartridge syringe |
JP4256643B2 (ja) * | 2001-12-27 | 2009-04-22 | 昭和薬品化工株式会社 | カートリッジ注射器、カートリッジ及び該注射器を備えた眼科用注射器セット |
US6830564B2 (en) * | 2002-01-24 | 2004-12-14 | Robin Scott Gray | Syringe and method of using |
JP4141156B2 (ja) | 2002-03-15 | 2008-08-27 | 日本ベクトン・ディッキンソン株式会社 | プランジャ後退制限機構付きプレフィルドシリンジ |
JP4247424B2 (ja) | 2002-05-30 | 2009-04-02 | 株式会社荒川樹脂 | 注射器用シリンジカバー及びシリンジカバーを用いた注射器 |
JP2004121344A (ja) | 2002-09-30 | 2004-04-22 | Terumo Corp | シリンジ用ガスケット、ガスケット付プランジャー、シリンジ及びプレフィルドシリンジ |
DK1549376T3 (da) | 2002-10-11 | 2011-12-05 | Becton Dickinson Co | Rensesprøjte med en indretning til at hæmme tilbagestrømning |
US20050010175A1 (en) | 2003-02-27 | 2005-01-13 | Beedon Daniel E. | Piston assembly for syringe |
AU2003214708A1 (en) * | 2003-03-14 | 2004-09-30 | Roque Humberto Ferreyro Irigoyen | Hydraulic device for the injection of bone cement in percutaneous vertebroplasty |
JP2004313369A (ja) | 2003-04-15 | 2004-11-11 | Menicon Co Ltd | カートリッジ注入器、カートリッジ及び該注入器を備えた眼科用注入器セット |
FR2855413B1 (fr) * | 2003-05-26 | 2005-12-30 | Becton Dickinson France | Seringue pre-remplie avec coiffe anti effraction |
US20050129569A1 (en) | 2003-12-15 | 2005-06-16 | Becton, Dickinson And Company | Terminal sterilization of prefilled containers |
EP1702634A4 (en) * | 2003-12-26 | 2010-08-04 | Wet Trust Japan Co Ltd | PORTABLE EJECTION AND INJECTION DEVICE |
US20050148947A1 (en) | 2003-12-30 | 2005-07-07 | Advanced Medical Optics, Inc. | Cannula locking device |
WO2005070485A1 (en) | 2004-01-09 | 2005-08-04 | Becton, Dickinson And Company | Positive displacement flush syringe |
WO2005072858A1 (en) | 2004-01-26 | 2005-08-11 | President And Fellows Of Harvard College | Fluid delivery system and method |
EP1715906A4 (en) | 2004-02-18 | 2008-12-17 | Univ Mcgill | DEVICE FOR INJECTING VISCOUS SUBSTANCE INTO HARD TISSUE |
DE102004009919B4 (de) | 2004-02-20 | 2007-02-08 | Schott Ag | Spritze, insbesondere für medizinische Anwendungen |
DK1767546T3 (da) | 2004-06-08 | 2012-04-23 | Chengdu Kanghong Biotechnologies Co Ltd | Angiogenese-inhiberende kimært protein og dets anvendelse |
JP4759232B2 (ja) * | 2004-07-02 | 2011-08-31 | テルモ株式会社 | 包装されたプレフィルドシリンジの製造方法 |
SI1802334T1 (sl) * | 2004-10-21 | 2012-12-31 | Genentech, Inc. | Postopek za zdravljenje intraokularnih neovaskularnih bolezni |
WO2006088650A2 (en) | 2005-02-02 | 2006-08-24 | Regeneron Pharmaceuticals, Inc. | Method of treating eye injury with local administration of a vegf inhibitor |
WO2006128564A1 (en) | 2005-05-31 | 2006-12-07 | Baxter International Inc. | Polypropylene hollow barrel with sliding coated rubber piston |
JP4584057B2 (ja) | 2005-07-08 | 2010-11-17 | テルモ株式会社 | プレフィルドシリンジ |
DE102005037962A1 (de) | 2005-08-11 | 2007-02-15 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Spritze |
JP2007155086A (ja) | 2005-12-08 | 2007-06-21 | Matsushita Electric Ind Co Ltd | 断熱箱体および冷蔵庫 |
JP4848784B2 (ja) * | 2006-02-02 | 2011-12-28 | ニプロ株式会社 | プランジャーとこれを用いたシリンジ及びプレフィルドシリンジ |
ATE406926T1 (de) | 2006-02-14 | 2008-09-15 | Gerresheimer Buende Gmbh | Verfahren zum herstellen von vorfüllbaren spritzen |
GB0607401D0 (en) | 2006-04-12 | 2006-05-24 | Glaxosmithkline Biolog Sa | Novel device |
WO2007121915A1 (de) | 2006-04-21 | 2007-11-01 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Spritzenzylinder |
ES2406764T3 (es) * | 2006-06-16 | 2013-06-10 | Regeneron Pharmaceuticals, Inc. | Formulaciones que comprenden antagonistas de VEGF para administración intravítrea |
JP4131001B2 (ja) | 2006-07-28 | 2008-08-13 | 大成化工株式会社 | 定量吐出装置 |
EP1894590B1 (de) | 2006-08-30 | 2012-04-25 | Roche Diagnostics GmbH | Injektionsvorrichtung mit vereinfachter Stopfenrückhaltung |
US8038656B2 (en) | 2006-09-29 | 2011-10-18 | Tyco Healthcare Group Lp | Detachable plunger rod syringe |
US20080114306A1 (en) | 2006-11-03 | 2008-05-15 | Bare Rex O | Small volume syringe with writing portion |
WO2008077155A1 (en) | 2006-12-21 | 2008-06-26 | Genentech, Inc. | Sterilization of objects containing biological molecules |
US20080154213A1 (en) | 2006-12-21 | 2008-06-26 | Bruce Leigh Kiehne | Syringe with multiple plunger locks |
US8529521B2 (en) | 2007-04-23 | 2013-09-10 | Ultimed Inc. | Low-dosage syringe |
EP2167172B1 (en) | 2007-06-04 | 2019-03-06 | Becton, Dickinson and Company | Stopper and plunger rod for a pre-filled syringe |
US7972302B2 (en) | 2007-06-12 | 2011-07-05 | Becton, Dickinson And Company | Syringe with disabling mechanism |
RU2488410C2 (ru) | 2007-06-12 | 2013-07-27 | Бектон, Дикинсон Энд Компани | Шприц с механизмом приведения его в неработоспособное состояние |
JP4853394B2 (ja) | 2007-06-15 | 2012-01-11 | ニプロ株式会社 | プレフィルドシリンジ |
JP3134991U (ja) | 2007-06-19 | 2007-08-30 | 株式会社トップ | プレフィルドシリンジ用ガスケット |
ES2376761T3 (es) | 2007-07-31 | 2012-03-16 | Al.Chi.Mi.A. S.R.L. | Método para realizar un dispositivo para tratamientos oftálmicos |
WO2009030976A1 (en) | 2007-09-03 | 2009-03-12 | Becton Dickinson France | Medical device and smooth coating therefor |
EP2201380B1 (en) | 2007-10-22 | 2016-06-01 | Becton Dickinson and Company | Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution |
PL2235395T3 (pl) | 2008-01-24 | 2012-05-31 | Meflex Telecontrol Gmbh & Co Kg | Końcówka dla linki napędowej, linka napędowa, sposób wytwarzania końcówki, oraz sposób wytwarzania linki napędowej |
CN103720587A (zh) | 2008-02-07 | 2014-04-16 | 安姆根有限公司 | 稳定化的蛋白组合物 |
US20100152646A1 (en) | 2008-02-29 | 2010-06-17 | Reshma Girijavallabhan | Intravitreal injection device and method |
US9295776B2 (en) * | 2008-04-11 | 2016-03-29 | Medtronic Minimed, Inc. | Reservoir plunger head systems and methods |
JP5163882B2 (ja) | 2008-05-27 | 2013-03-13 | 澁谷工業株式会社 | 滅菌方法 |
CN101640886B (zh) | 2008-07-29 | 2012-04-25 | 上海华为技术有限公司 | 鉴权方法、重认证方法和通信装置 |
JP5284720B2 (ja) | 2008-08-07 | 2013-09-11 | 株式会社トクヤマデンタル | 流動性部材注出器および流動性部材注出方法 |
WO2010024209A1 (ja) | 2008-08-25 | 2010-03-04 | 電気化学工業株式会社 | 注射器 |
JP5074330B2 (ja) | 2008-09-02 | 2012-11-14 | 株式会社エアレックス | プレフィルドシリンジの除染方法 |
US20100087796A1 (en) * | 2008-10-03 | 2010-04-08 | Reichert, Inc. | Method For Controlling A Pump Drive |
JP2012505162A (ja) * | 2008-10-09 | 2012-03-01 | ワラタ ファーマシューティカルズ, インコーポレイテッド | 黄斑変性症関連障害を処置するためのscyllo−イノシトールの使用 |
US7678078B1 (en) | 2008-10-21 | 2010-03-16 | KMG Pharma LLC | Intravitreal injection device, system and method |
US8221353B2 (en) | 2008-10-21 | 2012-07-17 | KMG Pharma, Inc | Intravitreal injection device and system |
JP5099707B2 (ja) | 2008-10-27 | 2012-12-19 | シャープ株式会社 | 携帯情報端末およびその制御方法 |
CN107011425B (zh) | 2008-11-03 | 2021-01-01 | 分子组合公司 | 抑制vegf-a受体相互作用的结合蛋白 |
CN104117115B (zh) | 2008-11-26 | 2017-05-24 | 贝克顿·迪金森公司 | 单次使用自动失效注射器 |
EP2371406A4 (en) | 2008-12-03 | 2017-08-16 | Denka Company Limited | Syringe |
JP5314406B2 (ja) | 2008-12-15 | 2013-10-16 | 電気化学工業株式会社 | シリンジ包装用袋 |
WO2010081838A2 (en) * | 2009-01-14 | 2010-07-22 | Novartis Ag | Sterile prefilled container |
CN102341138B (zh) | 2009-03-09 | 2013-06-19 | 泰尔茂株式会社 | 垫圈及注射器 |
USH2251H1 (en) * | 2009-05-12 | 2011-01-04 | The United States Of America As Represented By The United States Department Of Veterans Affairs | Method of preparing multiple doses of a pharmaceutical solution from a single-dose |
JP2012528112A (ja) | 2009-05-28 | 2012-11-12 | グラクソ グループ リミテッド | 抗原結合タンパク質 |
AR078060A1 (es) | 2009-07-14 | 2011-10-12 | Novartis Ag | Descontaminacion de superficie de contenedores previamente llenados en empaque secundario |
JP5431051B2 (ja) | 2009-07-17 | 2014-03-05 | 株式会社大協精工 | 微少容量の注射器用ピストン及び該ピストンを取り付けたプランジャー |
US8813584B2 (en) | 2009-07-27 | 2014-08-26 | Eppendorf Ag | Syringe, syringe family and metering device |
EP2470243B1 (en) | 2009-08-28 | 2019-10-02 | Sanofi-Aventis Deutschland GmbH | Assembly kit for preparing of a pre-filled syringe |
EP3556412B1 (en) | 2009-10-29 | 2021-04-14 | W.L. Gore & Associates Inc. | Syringe stopper coated with expanded ptfe |
CN201578690U (zh) | 2010-01-21 | 2010-09-15 | 王建友 | 一种注射器 |
CN102821804B (zh) * | 2010-03-30 | 2015-06-10 | 泰尔茂株式会社 | 具有滑动性覆盖层的医疗用具及注射器 |
CA2795096C (en) | 2010-03-31 | 2021-10-26 | Ocuject, Llc | Device and method for intraocular drug delivery |
JPWO2011125475A1 (ja) * | 2010-03-31 | 2013-07-08 | テルモ株式会社 | シリンジ |
US9408746B2 (en) | 2010-03-31 | 2016-08-09 | Ocuject, Llc | Device and method for intraocular drug delivery |
JP5719522B2 (ja) | 2010-03-31 | 2015-05-20 | テルモ株式会社 | 薬剤投与器具及び薬剤注射装置 |
AR081361A1 (es) | 2010-04-30 | 2012-08-29 | Molecular Partners Ag | Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a |
US8754862B2 (en) * | 2010-07-11 | 2014-06-17 | Lester F. Ludwig | Sequential classification recognition of gesture primitives and window-based parameter smoothing for high dimensional touchpad (HDTP) user interfaces |
JP5907966B2 (ja) | 2010-08-05 | 2016-04-26 | フォーサイト・ビジョン フォー・インコーポレーテッド | 埋め込み型治療デバイス |
CA2807508A1 (en) | 2010-08-05 | 2012-02-09 | Forsight Vision4, Inc. | Subconjunctival implant for posterior segment drug delivery |
JP2012045046A (ja) | 2010-08-24 | 2012-03-08 | Gc Corp | 歯科用シリンジ |
US20120078219A1 (en) | 2010-09-29 | 2012-03-29 | Tyco Healthcare Group Lp | Syringe Assembly |
FR2966044B1 (fr) | 2010-10-18 | 2012-11-02 | Sanofi Pasteur | Procede de conditionnement d'un vaccin contenant un adjuvant d'aluminium |
EP2682145B1 (en) | 2011-03-01 | 2020-11-25 | Terumo Kabushiki Kaisha | Syringe and syringe assembly |
US20120271245A1 (en) * | 2011-04-21 | 2012-10-25 | Achan Jr Leonard | Malleable stopper for a syringe |
HUE043538T2 (hu) | 2011-04-25 | 2019-08-28 | Icon Bioscience Inc | Dózisvezetõ eszköz injekciós fecskendõhöz |
US20130012918A1 (en) | 2011-07-07 | 2013-01-10 | Gary Foster | Steady grip ophthalmic surgical syringe and method |
JP2013116289A (ja) | 2011-12-05 | 2013-06-13 | Daikyo Seiko Ltd | 医薬品用注射器 |
US9421129B2 (en) | 2012-04-02 | 2016-08-23 | Ocuject, Llc | Intraocular delivery devices and methods therefor |
US10780228B2 (en) | 2012-05-07 | 2020-09-22 | Medline Industries, Inc. | Prefilled container systems |
HRP20220558T1 (hr) | 2012-06-01 | 2022-06-10 | Novartis Ag | Štrcaljka |
JOP20200175A1 (ar) | 2012-07-03 | 2017-06-16 | Novartis Ag | حقنة |
WO2014134577A1 (en) | 2013-03-01 | 2014-09-04 | Sio2 Medical Products, Inc. | Plasma or cvd pre-treatment for lubricated pharmaceutical package, coating process and apparatus |
KR101704883B1 (ko) | 2014-06-12 | 2017-02-09 | 동국대학교 경주캠퍼스 산학협력단 | 클라도스포륨 및 류코노스톡 시트륨 균주를 이용한 진세노사이드 함량이 증가된 홍삼 제제 및 이의 제조방법 |
JP6449569B2 (ja) | 2014-06-25 | 2019-01-09 | Necプラットフォームズ株式会社 | 位相補正装置、位相補正方法、及び位相補正プログラム |
JP2020531057A (ja) | 2017-06-29 | 2020-11-05 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | 薬品容器にいっぱいに充填するためのデバイス及び方法 |
-
2013
- 2013-05-30 HR HRP20220558TT patent/HRP20220558T1/hr unknown
- 2013-05-30 EP EP13727570.7A patent/EP2854762A1/en not_active Withdrawn
- 2013-05-30 DK DK19161189.6T patent/DK3536310T3/da active
- 2013-05-30 LT LTEP19161189.6T patent/LT3536310T/lt unknown
- 2013-05-30 EP EP20198921.7A patent/EP3777834B1/en active Active
- 2013-05-30 ES ES19161189T patent/ES2881196T3/es active Active
- 2013-05-30 ES ES20198921T patent/ES2913198T3/es active Active
- 2013-05-30 JP JP2015514516A patent/JP6781546B2/ja active Active
- 2013-05-30 MY MYPI2014003096A patent/MY165727A/en unknown
- 2013-05-30 BR BR112014029795-9A patent/BR112014029795B1/pt active IP Right Grant
- 2013-05-30 PT PT191611896T patent/PT3536310T/pt unknown
- 2013-05-30 PT PT201562741T patent/PT3679922T/pt unknown
- 2013-05-30 EA EA201492261A patent/EA033161B1/ru not_active IP Right Cessation
- 2013-05-30 CN CN201380028946.2A patent/CN104780906A/zh active Pending
- 2013-05-30 PL PL20156274T patent/PL3679922T3/pl unknown
- 2013-05-30 PL PL21164847.2T patent/PL3858405T3/pl unknown
- 2013-05-30 KR KR1020217008444A patent/KR102288287B1/ko active IP Right Grant
- 2013-05-30 PL PL20198921T patent/PL3777834T3/pl unknown
- 2013-05-30 CA CA2875193A patent/CA2875193A1/en not_active Abandoned
- 2013-05-30 HR HRP20211572TT patent/HRP20211572T1/hr unknown
- 2013-05-30 DE DE202013012825.9U patent/DE202013012825U1/de not_active Expired - Lifetime
- 2013-05-30 CA CA3126069A patent/CA3126069A1/en not_active Abandoned
- 2013-05-30 KR KR1020227012006A patent/KR102453181B1/ko active IP Right Grant
- 2013-05-30 EP EP20156274.1A patent/EP3679922B1/en active Active
- 2013-05-30 LT LTEP20198921.7T patent/LT3777834T/lt unknown
- 2013-05-30 SG SG11201407241QA patent/SG11201407241QA/en unknown
- 2013-05-30 PT PT211648472T patent/PT3858405T/pt unknown
- 2013-05-30 ES ES20156274T patent/ES2895406T3/es active Active
- 2013-05-30 EP EP21164847.2A patent/EP3858405B1/en active Active
- 2013-05-30 MA MA42648A patent/MA42648B1/fr unknown
- 2013-05-30 HU HUE20156274A patent/HUE055994T2/hu unknown
- 2013-05-30 SI SI201332047T patent/SI3858405T1/sl unknown
- 2013-05-30 SI SI201331901T patent/SI3536310T1/sl unknown
- 2013-05-30 US US14/403,801 patent/US20150105734A1/en not_active Abandoned
- 2013-05-30 NZ NZ702313A patent/NZ702313A/en unknown
- 2013-05-30 MA MA37599A patent/MA37599A1/fr unknown
- 2013-05-30 SI SI201331933T patent/SI3679922T1/sl unknown
- 2013-05-30 AR ARP130101908A patent/AR091817A1/es active IP Right Grant
- 2013-05-30 DK DK20198921.7T patent/DK3777834T3/da active
- 2013-05-30 DK DK21164847.2T patent/DK3858405T3/da active
- 2013-05-30 AU AU2013269594A patent/AU2013269594C1/en active Active
- 2013-05-30 PL PL19161189T patent/PL3536310T3/pl unknown
- 2013-05-30 IN IN9689DEN2014 patent/IN2014DN09689A/en unknown
- 2013-05-30 PT PT201989217T patent/PT3777834T/pt unknown
- 2013-05-30 HU HUE19161189A patent/HUE055556T2/hu unknown
- 2013-05-30 MX MX2014014722A patent/MX2014014722A/es unknown
- 2013-05-30 SG SG10201900193YA patent/SG10201900193YA/en unknown
- 2013-05-30 WO PCT/EP2013/061215 patent/WO2013178771A1/en active Application Filing
- 2013-05-30 DK DK20156274.1T patent/DK3679922T3/da active
- 2013-05-30 ES ES21164847T patent/ES2948322T3/es active Active
- 2013-05-30 KR KR1020207035156A patent/KR102232708B1/ko active IP Right Grant
- 2013-05-30 EP EP19161189.6A patent/EP3536310B1/en active Active
- 2013-05-30 PE PE2014002246A patent/PE20142396A1/es active IP Right Grant
- 2013-05-30 SI SI201331983T patent/SI3777834T1/sl unknown
- 2013-05-30 LT LTEP20156274.1T patent/LT3679922T/lt unknown
- 2013-05-30 KR KR1020217024698A patent/KR102386843B1/ko active IP Right Grant
- 2013-05-30 KR KR1020147033198A patent/KR20150021924A/ko active Application Filing
- 2013-05-31 TW TW102119459A patent/TW201402165A/zh unknown
-
2014
- 2014-11-03 ZA ZA2014/08019A patent/ZA201408019B/en unknown
- 2014-11-07 TN TN2014000471A patent/TN2014000471A1/fr unknown
- 2014-11-24 IL IL235882A patent/IL235882B/en active IP Right Grant
- 2014-11-27 CO CO14261546A patent/CO7141462A2/es unknown
- 2014-11-28 PH PH12014502675A patent/PH12014502675A1/en unknown
- 2014-11-28 CL CL2014003251A patent/CL2014003251A1/es unknown
- 2014-12-01 MX MX2020005315A patent/MX2020005315A/es unknown
- 2014-12-01 GT GT201400279A patent/GT201400279A/es unknown
-
2015
- 2015-04-10 HK HK15103519.9A patent/HK1202816A1/zh unknown
-
2018
- 2018-11-05 JP JP2018208290A patent/JP6920269B2/ja active Active
-
2019
- 2019-05-10 US US16/409,291 patent/US11103644B2/en active Active
-
2020
- 2020-02-14 US US16/791,505 patent/US11147925B2/en active Active
- 2020-02-26 IL IL272913A patent/IL272913B2/en unknown
- 2020-03-06 US US16/811,430 patent/US11110226B2/en active Active
- 2020-03-12 JP JP2020043041A patent/JP7026991B2/ja active Active
-
2021
- 2021-02-12 US US17/174,981 patent/US11179521B2/en active Active
- 2021-04-05 JP JP2021064330A patent/JP7075521B2/ja active Active
- 2021-06-01 US US17/335,684 patent/US11185635B2/en active Active
- 2021-07-08 HR HRP20211088TT patent/HRP20211088T1/hr unknown
- 2021-07-26 CY CY20211100667T patent/CY1124375T1/el unknown
- 2021-08-16 JP JP2021132366A patent/JP7042954B2/ja active Active
- 2021-08-25 JP JP2021137017A patent/JP2021184827A/ja not_active Withdrawn
- 2021-10-13 US US17/500,174 patent/US20220031952A1/en not_active Abandoned
- 2021-10-14 CY CY20211100891T patent/CY1124585T1/el unknown
-
2022
- 2022-02-15 JP JP2022021374A patent/JP2022081491A/ja not_active Withdrawn
- 2022-05-12 CY CY20221100332T patent/CY1125174T1/el unknown
- 2022-08-22 JP JP2022131761A patent/JP2022166261A/ja not_active Withdrawn
- 2022-08-31 IL IL296105A patent/IL296105B2/en unknown
- 2022-12-09 US US18/063,918 patent/US12048837B2/en active Active
-
2024
- 2024-07-01 US US18/760,445 patent/US20240350740A1/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5181918A (en) * | 1990-08-10 | 1993-01-26 | Thera Patent Gmbh & Co. Kg Gesellschaft Fuer Industrielle Schutzrechte | Granules syringe |
DE19613035B4 (de) * | 1996-03-19 | 2007-12-13 | Ferring Gmbh | System mit einer Spritze und einem Griffstück |
US20060293270A1 (en) * | 2005-06-22 | 2006-12-28 | Adamis Anthony P | Methods and compositions for treating ocular disorders |
WO2007035621A1 (en) * | 2005-09-16 | 2007-03-29 | (Osi) Eyetech, Inc. | Ophthalmic syringe |
DE102008005938A1 (de) * | 2008-01-24 | 2009-07-30 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Vorgefüllte Spritze und Verfahren zum Verpacken einer Spritze |
CN102065939A (zh) * | 2008-06-17 | 2011-05-18 | 电气化学工业株式会社 | 注射器 |
CN201263820Y (zh) * | 2008-09-02 | 2009-07-01 | 甘肃成纪生物药业有限公司 | 双室卡式瓶粉针剂预灌装注射器 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108290004A (zh) * | 2015-11-18 | 2018-07-17 | 福尔密孔股份公司 | 含有vegf拮抗剂的预填充塑料注射器 |
CN112657020B (zh) * | 2016-01-15 | 2022-09-27 | W.L.戈尔及同仁股份有限公司 | 注射器柱塞组件 |
US12036395B2 (en) | 2016-01-15 | 2024-07-16 | W.L. Gore & Associates, Inc. | Automated system for assembling a pre-filled syringe |
CN109475429A (zh) * | 2016-06-30 | 2019-03-15 | 东佩制药股份公司 | 容量控制滴管 |
CN110312541A (zh) * | 2017-02-17 | 2019-10-08 | 贝克顿·迪金森公司 | 带有塞子引导件的注射器和柱塞杆 |
CN111148539A (zh) * | 2017-09-29 | 2020-05-12 | 豪夫迈·罗氏有限公司 | 预填充式注射器和制备预填充式注射器的方法 |
CN112188906A (zh) * | 2018-05-24 | 2021-01-05 | 诺华股份有限公司 | 药物自动输送装置 |
CN112188906B (zh) * | 2018-05-24 | 2023-10-27 | 诺华股份有限公司 | 药物自动输送装置 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104780906A (zh) | 注射器 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150715 |
|
WD01 | Invention patent application deemed withdrawn after publication |